Посмотрите: Кафе возле Московского вокзала https://ftour.otzyv.ru/tema/229148/

sultancbr.online


GILEAD STOCK ANALYSIS

GILD has a market cap or net worth of $ billion. The enterprise value is $ billion. Market Cap, B. Enterprise Value, B. Important. The Gilead Sciences Inc stock price today is What Is the Stock Symbol for Gilead Sciences Inc? The stock ticker symbol for Gilead Sciences Inc is GILD. Based on short-term price targets offered by 24 analysts, the average price target for Gilead Sciences comes to $ The forecasts range from a low of $ Stock analysis for Gilead Sciences Inc (GILD:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Gilead Sciences Inc. ; Open. $ Previous Close$ ; YTD Change. %. 12 Month Change. % ; Day Range · 52 Wk Range -

Gilead Sciences, Inc. analysts consensus, targets, ratings and recommendations | Nasdaq: GILD | Nasdaq. Stock Price Forecast The 16 analysts with month price forecasts for Gilead Sciences stock have an average target of , with a low estimate of 69 and a. Key Data. Open $; Day Range - ; 52 Week Range - ; Market Cap $B; Shares Outstanding B; Public Float B; Beta According to analysts, GILD price target is USD with a max estimate of USD and a min estimate of USD. Check if this forecast comes true in a. On average, Wall Street analysts predict that Gilead Sciences's share price could reach $ by Sep 4, The average Gilead Sciences stock price. The high in the last 52 weeks of Gilead Sciences stock was According to the current price, Gilead Sciences is % away from the week high. What are. Based on analysts offering 12 month price targets for GILD in the last 3 months. The average price target is $ with a high estimate of $95 and a low. Earnings Growth. Earnings for Gilead Sciences are expected to grow by % in the coming year, from $ to $ per share. Price to Earnings Ratio vs. the. Gilead Sciences Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Gilead Sciences Inc ; Previous Close: ; Open: ; Volume: 9,, ; 3 Month Average Trading Volume: ; Shares Out (Mil): 1, Gilead Sciences created and sells the world's top-selling HIV medications, Truvada and Atripla, and commands about 75% of the US treatment market and more than.

A high-level overview of Gilead Sciences, Inc. (GILD) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and. Gilead's revenue grew 5% with broad-based growth from HIV (3%), liver disease (17%), and oncology (15%). HIV treatment regimen Biktarvy grew 8% as it continues. The current price of GILD is USD — it has decreased by −% in the past 24 hours. Watch Gilead Sciences, Inc. stock price performance more closely on. Quote Overview ; Most Accurate Est: ; Current Qtr Est: ; Current Yr Est: ; Prior Year EPS: ; Exp EPS Growth (yr). %. GILD Stock Overview · Trading at % below our estimate of its fair value · Earnings are forecast to grow % per year · Large one-off items impacting. Gilead Sciences Inc. ; Next Fiscal Year Estimate, ; Median PE on Next FY Estimate, N/A ; High, $ ; Median, $ ; Low, $ Find the latest Gilead Sciences, Inc. (GILD) stock quote, history, news and other vital information to help you with your stock trading and investing. Gilead Sciences (GILD) has a Smart Score of 10 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund. View Gilead Sciences, Inc. GILD stock quote prices, financial information, real-time forecasts, and company news from CNN.

The stock lies in the middle of a strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the. Key Stats · Market CapB · Shares OutB · 10 Day Average VolumeM · Dividend · Dividend Yield% · Beta · YTD % Change The intrinsic value of one GILD stock under the Base Case scenario is USD. Compared to the current market price of USD, Gilead Sciences Inc is. Gilead Sciences (GILD) · After Hours PM ET 08/30/ $ %. Previous Close · $ · ; % · Volume: Mil · Volume % Chg: 6% · Get. Key statistics. On Friday, Gilead Sciences Inc (GILD:NSQ) closed at , % below its week high of , set on Jan 19, Data delayed at least.

Gilead Sciences stock surges amid earnings beat and analyst upgrades

The stock price for Gilead Sciences (NASDAQ: GILD) is $ last updated September 6, at PM EDT. Q. Does Gilead Sciences (GILD) pay a dividend? A. Comparing Gilead Sciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to. From what 28 stock analysts predict, the share price for Gilead Sciences Inc (GILD) might increase by % in the next year. This is based on a month. Real-time Price Updates for Gilead Sciences Inc (GILD-Q), along with buy or sell indicators, analysis, charts, historical performance, news and more.

Bad Credit Credit Cards Unsecured Instant Approval Canada | Pee Holder For Drug Test Male

1 2 3 4

Copyright 2019-2024 Privice Policy Contacts SiteMap RSS